Tumour, Oxidative Stress and Host T Cell Response: Cementing the Dominance

Scandinavian Journal of Immunology

Volumn 82, Issue 6, 2015, Pages 477-488

  Bhattacharyya, S ^a   Saha, J ^a  

^a Sidho Kanho Birsha University   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; ARGINASE 1; BILIRUBIN GLUCURONIDE; CARNOSINE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FREE RADICAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HOMOCARNOSINE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; NITRIC OXIDE; OXYGEN RADICAL; PEROXY RADICAL; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TAURINE; THIOCTIC ACID; THIOREDOXIN; URIC ACID; XANTHINE DEHYDROGENASE;

BONE MARROW SUPPRESSION; CANCER ASSOCIATED FIBROBLAST; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; DNA DAMAGE; FIBROBLAST; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IONIZING RADIATION; MEDIATOR RELEASE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; ANIMAL; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; NEOPLASM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; DNA DAMAGE; HUMANS; INFLAMMATION; MICE; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84945263326     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12350     Document Type: Review

References (108)

1. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002;30:620-50.
2. Richter C, Gogvadze V, Laffranchi R et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995;1271:67-74.
3. Pentland AP. Active oxygen mechanisms of UV in inflammation. Adv Exp Med Biol 1994;366:87-97.
4. Shadyro OI, Yurkova IL, Kisel MA. Radiation-induced peroxidation and fragmention of lipids in a model membrane. Int J Radiat 2002;78:211-7.
5. Obata T, Yamanaka Y, Kinemuchi H, Oreland L. Release of dopamine by perfusion with 1-methyl-4-phenylpyridiniumion (MPP) into the striatum is associated with hydroxyl free radical generation. Brain Res 2001;906:170-5.
6. Ray RS, Mehrotra S, Shanker U, Babu GS, Joshi PC, Hanss RK. Evaluation of UV-induced superoxide radical generation potential of some common antibiotics. Drug Chem Toxicol 2001;24:191-200.
7. Klaunig JA, Kamendulis LM, Hocevar AB. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010;38:96-109.
8. Weinberg F, Chandel NS. Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci 2009;66:3663-73.
9. Allen RG, Tresini M. Oxidative status and gene regulation. Free Radic Biol Med 2000;28:463-99.
10. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000;97:8841-8.
11. Dahlgren C, Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 1999;232:3-14.
12. Babior BN, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002;397:342-4.
13. Forman HJ, Torres M. Redox signaling in macrophages. Mol Aspects Med 2001;22:189-216.
14. Laroux FS, Pavlick KP, Hines IN. Role of nitric oxide in inflammation. Acta Physiol Scand 2001;173:113-8.
15. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S-8S.
16. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
17. Schraufstatter I, Hyslop PA, Jackson JH, Cochrane CG. Oxidant-induced DNA damage of target cells. J Clin Invest 1988;82:1040-50.
18. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
19. McCord JM, Fridovich I. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med 1988;5:363-9.
20. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10:1881-96.
21. Fiaschi T, Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. Int J Cell Biol 2012;2012: Article ID 762825, 8 pages.
22. Fruehauf JP, Trapp V. Reactive oxygen species: an Achilles' heel of melanoma? Expert Rev Anticancer Ther 2008;8:1751-7.
23. Church SL, Grant JW, Ridnour LA et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A 1993;90:3113-7.
24. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794-8.
25. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
26. Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 2010;20:65-71.
27. Reuter S, Gupta SC, Chaturvedi MM, Agarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-16.
28. Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009;86:1065-73.
29. Khaled YS, Ammori JB, Elkord E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol 2013;91:493-502.
30. Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol 2006;16:80-8.
31. Horiguchi S, Petersson M, Nakazawa T et al. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells. Cancer Res 1999;59:2950-6.
32. Pal S, Bhattacharyya S, Choudhuri T, Datta GK, Das T, Sa G. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detect Prev 2005;29:470-8.
33. Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res 2000;6:1351-64.
34. Martinez-Outschoorn UE, Lin Z, Trimmer C et al. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011;10:2504-20.
35. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
36. Dang CV. Links between metabolism and cancer. Genes Dev 2012;26:877-90.
37. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-76.
38. Chattopadhyay S, Bhattacharyya S, Saha B et al. Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins. PLoS ONE 2009;4:e7382.
39. Bhattacharyya S, Mandal D, Sen GS et al. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res 2007;67:362-70.
40. Van Ginderachter JA. Myelomonocytic subsets in tumor microenvironment. Macrophages. In: Biswas SK, Mantovani A, eds. Biology and Role in the Pathology of Diseases. New York, NY: Springer, 2014:405-23. ISBN 978-1-4939-1311-4
41. Quatromoni JG, Eruslanov E. Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res 2012;4:376-89.
42. Cheng P, Corzo CA, Luetteke N et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008;205:2235-49.
43. Dougherty ST, Eaves CJ, McBride WH, Dougherty GJ. Molecular mechanisms regulating TNF-alpha production by tumor-associated macrophages. Cancer Lett 1997;111:27-37.
44. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004;172:989-99.
45. Mazzoni A, Bronte V, Visintin A et al. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 2002;168:689-95.
46. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-76.
47. Martinez-Outschoorn UE, Balliet RM, Revadeneira DB et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010;9:3256-76.
48. Sampson N, Koziel R, Zenzmaier C et al. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol Endocrinol 2011;25:503-15.
49. Thoren FB, Betten A, Romero AI et al. Cutting edge: antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced in activation and apoptosis. J Immunol 2007;179:21-5.
50. Kasic T, Colombo P, Soldani C et al. Modulation of human T-cell functions by reactive nitrogen species. Eur J Immunol 2011;41:1843-9.
51. Cemerski S, van Meerwijk JP, Romagnoli P. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Eur J Immunol 2003;33:2178-85.
52. Los M, Droge W, Stricker K et al. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 1995;25:159-65.
53. Griffiths HR. ROS as signaling molecules in T cells - evidence for abnormal redox signaling in the autoimmune disease, rheumatoid arthritis. Redox Rep 2005;10:273-80.
54. King MR, Ismail AS, Davis LS et al. Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype. J Immunol 2006;176:2765-72.
55. Moghaddam AE, Gartlan KH, Kong L et al. Reactive carbonyls are a major Th2- inducing damage-associated molecular pattern generated by oxidative stress. J Immunol 2011;187:1626-33.
56. Malmberg KJ, Arulampalam V, Ichihara F et al. Inhibition of activated/memory (CD45RO+) T cells by oxidative stress associated with block of NF-κB activation. J Immunol 2001;167:2595-601.
57. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983;52:711-60.
58. Jones DP, Mody VC Jr, Carlson JL et al. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 2002;33:1290-300.
59. Yan Z, Banerjee R. Redox remodeling as an immunoregulatory strategy. Biochemistry 2010;49:1059-66.
60. Yan Z, Garg SK, Kipnis J et al. Extracellular redox modulation by regulatory T cells. Nat Chem Biol 2009;5:721-3.
61. Hamilos DL, Zelarney P, Mascali JJ. Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology 1989;18:223-35.
62. Suthanthiran M, Anderson ME, Sharma VK et al. Glutathione regulates activation dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 1990;87:3343-7.
63. Hadzic T, Li L, Cheng N et al. The role of low molecular weight thiols in T lymphocyte proliferation and IL-2 secretion. J Immunol 2005;175:7965-72.
64. Dunn G, Bruce A, Ikeda H, Old L, Schreiber R. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8.
65. Kiessling R, Wasserman K, Horiguchi S et al. Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999;7:353-62.
66. Mandal D, Bhattacharyya A, Lahiry L, Choudhuri T, Sa G, Das T. Failure in peripheral immunosurveillance due to thymic atrophy: importance of thymocyte maturation and apoptosis in adult tumor bearer. Life Sci 2005;77:2703-16.
67. Alexander JP, Kudoh S, Melsop KA et al. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 1993;53:1380-7.
68. Matsuda M, Petersson M, Lenkei R et al. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 1995;61:765-72.
69. Arista MC, Callopoli A, De Franceschi L et al. Flow cytometric study of lymphocyte subsets in patients at different stages of colorectal carcinoma. Dis Colon Rectum 1994;37:S30-4.
70. Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T, Sa G. Curcumin prevents tumor induced T-cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem 2007;282:15954-64.
71. Mandal D, Lahiry L, Bhattacharyya A, Bhattacharyya S, Sa G, Das T. Tumor- induced thymic involution via inhibition and its JAK-STAT signaling pathway of IL-7Rα: protection by black tea. Int Immunopharmacol 2006;6:433-44.
72. Mellqvist UH, Hansson M, Brune M et al. Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 2000;96:1961-8.
73. Ando T, Mimura K, Johansson CC et al. Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress. J Immunol 2008;181:8382-90.
74. Bhattacharyya S, Md Sakib Hossain D, Mohanty S et al. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell Mol Immunol 2010;7:306-15.
75. Mandal D, Bhattacharyya S, Lahiry L, Chattopadhyay S, Sa G, Das T. Black tea induced decrease in IL-10 and TGF-β in tumor cells promotes Th1/Tc1 response of tumor-bearer. Nutr Cancer 2007;58:213-21.
76. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;9:532-62.
77. Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3ζ chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 1996;93:13119-24.
78. Hildeman DA, Mitchell T, Teague TK et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999;10:735-44.
79. Gabrilovich DI, Nagaraj S. Myeloid-derived-suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-74.
80. Corzo CA, Condamine T, Lu L et al. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 2010;207:2439-53.
81. Jayaraman P, Parikh F, Lopez-Rivera E. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol 2012;188:5365-76.
82. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181:5791-802.
83. Monu NR, Allan BF. Myeloid derived suppressor cells and anti-tumor T cells: a complex relationship. Immunol Invest 2012;40:595-613.
84. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003;24:302-6.
85. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010;70:68-77.
86. Mougiakakos D, Johansson CC, Kiessling R. Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood 2009;113:3542-5.
87. Mougiakakos D, Johansson CC, Jitschin R et al. Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 2011;117:857-61.
88. Liyanage UK, Moore TT, Joo HG et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-61.
89. Hossain DM, Panda AK, Manna A et al. FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 2013;39:1057-69.
90. Wilke CM, Wu K, Zhao E, Wang G, Zou W. Prognostic significance of regulatory T cells in tumor. Int J Cancer 2010;127:748-58.
91. Beyer M, Schultze JL. Regulatory T cells in cancer. Blood 2006;108:804-11.
92. Yan Z, Garg SK, Banerjee R. Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J Biol Chem 2010;285:41525-32.
93. Napetschnig J, Wu H. Molecular basis of NF-κB signaling. Annu Rev Biophys 2013;42:443-68.
94. Baeuerle PA, Henkel T. Function and activation of NF-ΚB in the immune system. Annu Rev Immunol 1994;12:141-79.
95. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
96. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-κB activation: reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000;59:13-23.
97. Hayakawa M, Miyashita H, Sakamoto I et al. Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J 2003;22:3356-66.
98. Ghosh PA, Sica HA, Young J et al. Alterations in NFκB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res 1994;54:2969-72.
99. Uzzo RG, Clark PE, Rayman P et al. Alterations in NF-κB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst 1999;91:718-21.
100. Ling W, Rayman P, Uzzo R et al. Impaired activation of NFκB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IκBα. Blood 1998;92:1334-41.
101. Beg A, Baltimore D. An essential role of NF-κB in preventing TNFa induced cell death. Science 1996;274:782-4.
102. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995;92:5510-4.
103. 2 sensing. Science 2001;292:464-8.
104. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
105. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008;100:773-83.
106. Schroecksnadel K, Fischer B, Schennach H, Weiss G, Fuchs D. Antioxidants suppress Th1-type immune response in vitro. Drug Metab Lett 2007;1:166-71.
107. Winkler C, Schroecksnadel K, Schennach H, Fuchs D. Vitamin C and E suppress mitogen-stimulated peripheral blood mononuclear cells in vitro. Int Arch Allergy Immunol 2007;142:127-32.
108. Sen GS, Mohanty S, Hossain DM et al. Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer. J Biol Chem 2011;286:42232-47.